Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy: Diagnostic value and the work-up of sentinel node negative patients

NuklearMedizin

Volumn 50, Issue 1, 2011, Pages 33-38

  Dalus, Katharina ^a   Reitsamer, R ^a   Holzmannhofer, J ^a   Rendl, G ^a   Pirich, C ^a   Kronberger, C ^a   Rettenbacher, L ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Breast cancer; FDG; Lymphoscintigraphy; Neoadjuvant chemotherapy; PET CT; Sentinel lymph node biopsy

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CYCLOPHOSPHAMIDE; DISULFINE BLUE; DOCETAXEL; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; NANOCOLL TC 99M; TRASTUZUMAB;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; HUMAN; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 79952098824     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0320-10-05     Document Type: Article

References (28)

1. Bonadonna G et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998; 16: 93-100. (Pubitemid 28041584)
2. Dose-Schwarz J et al. Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen. Nuklearmedizin 2008; 47: 97-103. (Pubitemid 351881403)
3. 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. Eur J Nucl Med Mol Imaging 2009; 36: 1551-1557.
4. Fisher B et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998; 16: 2672-2685. (Pubitemid 28363030)
5. Gimbergues P et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 2008; 15: 1316-1321.
6. Heusner TA et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging 2009; 36: 1543-1550.
7. 18FDG PET/CT for the initial staging and therapy in primary breast cancer]. Gan To Kagaku Ryoho 2009; 36: 2526-2531.
8. Iwase H et al. Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment. Surg Today 2009; 39: 374-380.
9. Jones JL et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg 2005; 190: 517-520. (Pubitemid 41306067)
10. Kang SH et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg 2004; 28: 1019-1024. (Pubitemid 40109887)
11. Kuehn T et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005; 103: 451-461.
12. Lee S et al. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 2007; 102: 283-288. (Pubitemid 46474835)
13. Lyman GH et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-7720. (Pubitemid 46291835)
14. Menard JP et al. Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy. Eur J Surg Oncol 2009; 35: 916-920.
15. Newman EA et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 2007; 14: 2946-2952. (Pubitemid 47460622)
16. Noguchi M et al. Current controversies concerning sentinel lymph node biopsy for breast cancer. Breast Cancer Res Treat 2004; 84: 261-271. (Pubitemid 38445376)
17. Patel NA et al. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer. Am Surg 2004; 70: 696-700.
18. Reitsamer R et al. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 2003; 84: 63-67. (Pubitemid 37247910)
19. Sabel MS et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 2003; 186: 102-105. (Pubitemid 37289077)
20. Schwartz GF et al. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Cancer 116: 1243-1251.
21. Shen J et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 2007; 109: 1255-1263. (Pubitemid 46466551)
22. Van der Hage JA et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001; 19: 4224-4237. (Pubitemid 33081640)
23. Van Deurzen CH et al. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 2009; 45: 3124-3130.
24. Veronesi U et al. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 1995; 222: 612-618.
25. Vigario A et al. Primary chemotherapy effect in sentinel node detection in breast cancer. Clin Nucl Med 2003; 28: 553-557. (Pubitemid 38281919)
26. Vogt H et al. Procedure guideline for sentinel lymph node diagnosis. Nuklearmedizin 2010; 49: 167-172.
27. Wolmark N et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001; 30: 96-102.
28. Xing Y et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006; 93: 539-546.